|
Published by: Freedonia Group Inc
Published: Oct. 1, 2008 - 238 Pages
Table of Contents
- INTRODUCTION
- GLOSSARY OF TERMS
- I. EXECUTIVE SUMMARY
- II. MARKET ENVIRONMENT
- General
- Macroeconomic Trends
- Demographic Patterns
- Trends in Health Care
- Health Insurance Coverage
- Diseases & Disorders
- Acute Conditions
- Chronic Conditions
- National Health Expenditures
- Types
- Sources
- Medical Providers
- Acute Care Hospitals
- Outpatient Clinics
- Skilled Nursing Homes
- Physicians
- Patient Activity
- Acute Care Hospital Admissions
- Surgical Procedures
- Outpatient Episodes
- Diagnostic Tests
- Pharmaceutical Industry Trends
- Regulation
- Research & Development
- Product Shipments
- Therapeutic Classes
- Trends in Shipments
- Trends in In Vitro Diagnostics
- Regulation
- Research & Development
- Product Shipments
- Life Science Research Trends
- Funding
- Activities
- Biochip Market Overview
- Markets Served
- Demand Patterns
- US Trade
- International Markets
- III. BIOCHIP TECHNOLOGIES
- General
- Genomic Technology
- DNA Structure
- Genetic Variants
- Gene Expression
- SNP Identification & Genotyping
- Proteomics
- Protein Structure
- Commercial Applications
- Biochip Production Methods
- Photolithography
- Microfluidic Technology
- Sample Preparation & Hybridization Processes
- Biochip Detection Methods
- Biochip Data Analysis
- Competitive Technologies
- Research Technologies
- In Vitro Diagnostic (IVD) Technologies
- Drug Discovery Technologies
- IV. BIOCHIP PRODUCTS & SERVICES
- General
- Biochip Products
- Biochips (Microarrays)
- DNA Chips
- Applications
- Producers
- Protein Chips
- Applications
- Producers
- Laboratory Chips
- Applications
- Producers
- Biochip Reagents & Consumables
- Extraction Reagents
- Labeling Kits
- Other Reagents & Consumables
- Biochip Instruments
- Detection Instruments
- Technologies
- Products & Producers
- Production Instruments
- Production Methods
- Products & Producers
- Sample Preparation & Hybridization Instruments
- Sample Preparation Instruments
- Hybridization Instruments
- Biochip Software
- Open Programs
- Closed Programs
- Biochip Services
- Contract & Related Services
- Maintenance, Repair & Technical Support Services
- V. BIOCHIP APPLICATIONS
- General
- Drug Discovery
- Gene Expression
- SNP Identification & Genotyping
- Proteomics
- Life Science Research
- In Vitro Diagnostic Testing
- Disease Management
- Forensic Medicine
- Drugs-of-Abuse Testing
- Other Applications
- Agriculture
- Defense & Military
- Industrial & Environmental Applications
- VI. BIOCHIP MARKETS
- General
- Pharmaceutical Companies
- Market Trends
- Biochip Trends
- Biotechnology Companies
- Colleges & Universities
- Medical Providers
- Hospitals
- Clinical Laboratories
- Other Medical Providers
- Government Agencies
- Other Markets
- VII. INDUSTRY STRUCTURE
- General
- Market Share
- Competitive Strategies
- Mergers & Acquisitions
- Licensing & Related Agreements
- Research & Development
- Marketing & Distribution
- Manufacturing Activities
- Company Profiles
- Affymetrix Incorporated
- Agilent Technologies Incorporated
- Applera Corporation, see Applied Biosystems
- Applied Biosystems Incorporated
- Beckman Coulter Incorporated
- Becton, Dickinson and Company
- Bio-Rad Laboratories Incorporated
- bioMerieux SA
- BioTrove Incorporated
- Caliper Life Sciences Incorporated
- Cepheid
- Clontech Laboratories Incorporated, see Takara Holdings
- CombiMatrix Corporation
- Fluidigm Corporation
- General Electric Company
- Helicos BioSciences Corporation
- Illumina Incorporated
- Invitrogen Corporation
- Johnson & Johnson
- MDS Incorporated
- Micronics Incorporated
- Molecular Devices Corporation, see MDS
- Pacific Biosciences of California Incorporated
- PerkinElmer Incorporated
- QIAGEN NV
- Roche Holding Limited
- SEQUENOM Incorporated
- Siemens AG
- Solexa Incorporated, see Illumina
- Takara Holdings Incorporated
- Veridex LLC, see Johnson & Johnson
- Other Companies Mentioned in the Study
- LIST OF TABLES
- SECTION I -- EXECUTIVE SUMMARY
- Summary Table
- SECTION II -- MARKET ENVIRONMENT
- 1 Macroeconomic Indicators
- 2 Population by Age Group
- 3 Health Insurance Coverage of the US Population
- 4 Acute Conditions by Type
- 5 Chronic Conditions by Type
- 6 National Health Expenditures by Type & Source
- 7 Medical Providers by Type
- 8 Patient Activity by Type
- 9 Pharmaceutical Research & Development Expenditures by Type & Object
- 10 Pharmaceutical Shipments by Therapeutic Class
- 11 In Vitro Diagnostic (IVD) Product Demand by Methodology & Type
- 12 Life Science Research & Development Expenditures by Objective & Performing Sector
- 13 Biochip Product & Service Demand, 1998-2007
- 14 US Trade in Biochip Products
- 15 World Biochip Product & Service Demand
- SECTION III -- BIOCHIP TECHNOLOGIES
- 1 Biochip Product & Service Demand by Technology
- 2 Gene Expression - Biochip Product & Service Demand
- 3 SNP Identification & Genotyping - Biochip Product & Service Demand
- 4 Proteomic & Related Technologies - Biochip Product & Service Demand
- SECTION IV -- BIOCHIP PRODUCTS & SERVICES
- 1 Biochip Product & Service Demand by Category
- 2 Biochip Product Demand by Type
- 3 Biochip (Microarray) Demand by Type
- 4 DNA Chip (Microarray) Demand by Application
- 5 Protein Chip (Microarray) Demand by Application
- 6 Laboratory Chip (Microarray) Demand by Application
- 7 Biochip Reagent & Consumable Demand by Application
- 8 Biochip Instrument Demand by Type
- 9 Biochip Detection Instrument Demand by Application
- 10 Biochip Production Instrument Demand by Application
- 11 Biochip Sample Preparation & Hybridization Instrument Demand by Application
- 12 Biochip Software Demand by Application
- 13 Biochip Service Demand by Type
- SECTION V -- BIOCHIP APPLICATIONS
- 1 Biochip Product & Service Demand by Application
- 2 Drug Discovery Demand - Biochip Products & Services
- 3 Life Science Research Demand - Biochip Products & Services
- 4 In Vitro Diagnostic Testing Demand - Biochip Products & Services
- 5 Disease Management Demand - Biochip Products & Services
- 6 Forensic Medicine Demand - Biochip Products & Services
- 7 Drugs-of-Abuse Testing Demand - Biochip Products & Services
- 8 Biochip Product & Service Demand in Other Applications
- SECTION VI -- BIOCHIP MARKETS
- 1 Biochip Product & Service Demand by Market
- 2 Pharmaceutical Industry Demand - Biochip Products & Services
- 3 Biotechnology Industry Demand - Biochip Products & Services
- 4 College & University Demand - Biochip Products & Services
- 5 Medical Provider Demand - Biochip Products & Services
- 6 Government Agency Demand - Biochip Products & Services
- 7 Biochip Product & Service Demand in Other Markets
- SECTION VII -- INDUSTRY STRUCTURE
- 1 Biochip Revenues by Company, 2007
- 2 Selected Acquisitions & Divestitures
- 3 Selected Cooperative Agreements
- LIST OF CHARTS
- SECTION III -- BIOCHIP TECHNOLOGIES
- 1 Biochip Product & Service Demand by Technology, 2007
- SECTION IV -- BIOCHIP PRODUCTS & SERVICES
- 1 Biochip Product Demand by Type, 2007
- 2 Biochip (Microarray) Demand by Type, 2007
- 3 Biochip Instrument Demand by Type, 2007
- SECTION V -- BIOCHIP APPLICATIONS
- 1 Biochip Product & Service Demand by Application, 2007
- 2 Drug Discovery Demand for Biochip Products & Services by Type, 2007
- SECTION VI -- BIOCHIP MARKETS
- 1 Biochip Product & Service Demand by Market, 2007
- SECTION VII -- INDUSTRY STRUCTURE
- 1 Biochip Products & Services Market Share by Company, 2007
AbstractUS demand to rise 9.9% annually though 2012
The US market for biochip products and services will increase 9.9 percent per year to $2.5 billion in 2012. Microarrays will sustain the largest portion of product demand based on their consumable nature and expanding applications in drug discovery, life science research, and clinical and forensic testing. DNA chips will continue to lead microarray sales, spurred by widening use in the identification and testing of potential new therapies and diagnostic targets. However, laboratory and protein microarrays will provide faster growth opportunities as the focus of drug discovery and life science research activities shifts from genomics to proteomics.
Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Get Full Details About This Report >>
|
